Gene: DNAAF8
Official Full Name: dynein axonemal assembly factor 8provided by HGNC
Gene Summary: Predicted to enable dynein complex binding activity. Predicted to be involved in outer dynein arm assembly. Located in dynein axonemal particle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18248 | DNAAF8 Knockout cell line (HeLa) | Human | DNAAF8 | 1:3~1:6 | Negative | Online Inquiry |
KO18249 | DNAAF8 Knockout cell line (HCT 116) | Human | DNAAF8 | 1:2~1:4 | Negative | Online Inquiry |
KO18250 | DNAAF8 Knockout cell line (HEK293) | Human | DNAAF8 | 1:3~1:6 | Negative | Online Inquiry |
KO18251 | DNAAF8 Knockout cell line (A549) | Human | DNAAF8 | 1:3~1:4 | Negative | Online Inquiry |
DNAAF8 Gene Knockout Cell Lines represent a revolutionary tool in the field of cellular and molecular biology, designed to facilitate the study of the DNAAF8 gene and its associated pathways. Through the precise application of CRISPR-Cas9 technology, these cell lines exhibit a complete knockout of the DNAAF8 gene, allowing researchers to investigate the gene's role in ciliary function, respiratory health, and various disease mechanisms.
The primary function of DNAAF8 is critical in the assembly and maintenance of cilia, hair-like structures essential for cell signaling and fluid movement in tissues. By studying the knockout cell lines, scientists can elucidate the downstream effects triggered by the absence of DNAAF8, providing insights into conditions such as primary ciliary dyskinesia and related disorders. These cell lines serve as invaluable models for investigating abnormalities in ciliogenesis and the pathophysiology of respiratory diseases.
The scientific importance of DNAAF8 Gene Knockout Cell Lines extends to their potential applications in both research and clinical settings. They are particularly beneficial for drug screening assays, and functional studies related to gene therapy, and can enhance our understanding of genetic disorders. Unlike traditional cell culture models that may not accurately reflect the genetic architecture of human diseases, DNAAF8 knockout lines offer a more precise representation, increasing the reliability of experimental outcomes.
Unique selling points of these knockout cell lines include their validated mutation profiles and robust performance across a variety of assays. This ensures that researchers can derive replicable and relevant data, ultimately accelerating the pipeline from discovery to application. Furthermore, their adaptability for use in high-throughput screening makes them an efficient choice compared to alternative models that may require more cumbersome modifications.
Research and clinical communities will find DNAAF8 Gene Knockout Cell Lines invaluable for their contribution to understanding genetic contributions to respiratory diseases, paving the way for targeted therapeutic interventions. As leaders in the development of advanced research tools, our company brings extensive expertise and a commitment to supporting scientists and clinicians in uncovering new biological pathways and developing novel treatments.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.